JLP Health

JLP Health GmbH employs cutting edge functional genomic technologies that enable the development of rational drugs to combat viral infection, cancer and other diseases with high unmet medical need. Combining specific cellular assays with our genetic screening technologies we develop a diverse project portfolio based on newly identified drug target structures and strive to move our findings to the clinics.

JLP Health GmbH is embedded in a dynamic international R&D Group with subsidiaries in Germany (www.acuslabs.com) and China (www.angalbio.com).